This company listing is no longer active
Mettler-Toledo International Past Earnings Performance
Past criteria checks 3/6
Mettler-Toledo International has been growing earnings at an average annual rate of 14%, while the Life Sciences industry saw earnings growing at 27.3% annually. Revenues have been growing at an average rate of 7.8% per year.
Key information
14.0%
Earnings growth rate
16.8%
EPS growth rate
Life Sciences Industry Growth | 26.8% |
Revenue growth rate | 7.8% |
Return on equity | n/a |
Net Margin | 22.2% |
Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Mettler-Toledo International makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 23 | 3,911 | 870 | 899 | 185 |
30 Jun 23 | 3,954 | 889 | 912 | 183 |
31 Mar 23 | 3,951 | 887 | 923 | 180 |
31 Dec 22 | 3,920 | 873 | 922 | 177 |
30 Sep 22 | 3,899 | 838 | 937 | 177 |
30 Jun 22 | 3,865 | 821 | 946 | 175 |
31 Mar 22 | 3,811 | 793 | 944 | 174 |
31 Dec 21 | 3,718 | 769 | 933 | 170 |
30 Sep 21 | 3,619 | 754 | 917 | 164 |
30 Jun 21 | 3,474 | 712 | 881 | 156 |
31 Mar 21 | 3,240 | 654 | 832 | 145 |
31 Dec 20 | 3,085 | 603 | 808 | 140 |
30 Sep 20 | 2,991 | 579 | 790 | 136 |
30 Jun 20 | 2,938 | 547 | 790 | 137 |
31 Mar 20 | 2,978 | 547 | 807 | 142 |
31 Dec 19 | 3,009 | 561 | 814 | 144 |
30 Sep 19 | 2,983 | 550 | 809 | 145 |
30 Jun 19 | 2,964 | 547 | 808 | 144 |
31 Mar 19 | 2,954 | 531 | 811 | 142 |
31 Dec 18 | 2,936 | 513 | 807 | 141 |
30 Sep 18 | 2,896 | 408 | 812 | 137 |
30 Jun 18 | 2,860 | 387 | 815 | 135 |
31 Mar 18 | 2,791 | 377 | 804 | 132 |
31 Dec 17 | 2,725 | 376 | 791 | 128 |
30 Sep 17 | 2,657 | 437 | 773 | 126 |
30 Jun 17 | 2,609 | 433 | 757 | 124 |
31 Mar 17 | 2,563 | 411 | 749 | 122 |
31 Dec 16 | 2,508 | 384 | 736 | 119 |
30 Sep 16 | 2,472 | 370 | 722 | 121 |
30 Jun 16 | 2,426 | 357 | 710 | 120 |
31 Mar 16 | 2,399 | 355 | 697 | 120 |
31 Dec 15 | 2,395 | 353 | 701 | 119 |
30 Sep 15 | 2,419 | 351 | 710 | 119 |
30 Jun 15 | 2,444 | 347 | 721 | 120 |
31 Mar 15 | 2,471 | 343 | 729 | 122 |
31 Dec 14 | 2,486 | 338 | 729 | 123 |
30 Sep 14 | 2,473 | 327 | 722 | 123 |
30 Jun 14 | 2,435 | 317 | 709 | 121 |
31 Mar 14 | 2,405 | 312 | 699 | 118 |
31 Dec 13 | 2,379 | 306 | 693 | 116 |
30 Sep 13 | 2,352 | 301 | 688 | 114 |
30 Jun 13 | 2,339 | 298 | 686 | 113 |
31 Mar 13 | 2,330 | 291 | 682 | 112 |
31 Dec 12 | 2,342 | 291 | 684 | 113 |
Quality Earnings: MTO has high quality earnings.
Growing Profit Margin: MTO's current net profit margins (22.2%) are higher than last year (21.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MTO's earnings have grown by 14% per year over the past 5 years.
Accelerating Growth: MTO's earnings growth over the past year (3.9%) is below its 5-year average (14% per year).
Earnings vs Industry: MTO earnings growth over the past year (3.9%) did not outperform the Life Sciences industry 12.2%.
Return on Equity
High ROE: MTO's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.